Serum Lipid Levels and Thromboembolic Complications During Estrogen Therapy of Prostatic Cancer
- 1 January 1975
- journal article
- research article
- Published by Taylor & Francis in Scandinavian Journal of Urology and Nephrology
- Vol. 9 (2), 89-93
- https://doi.org/10.3109/00365597509180912
Abstract
The effect of diethylstilboestrol diphosphate (DES) and polyestradiol phosphate (PES) on the serum lipid levels of 40 prostatic cancer patients was investigated during a long-term follow-up. In patients treated with DES serum triglyceride levels elevated significantly whereas changes in serum cholesterol and total lipid contents were not significant. In patients treated with PES no significant changes in serum triglyceride, cholesterol and total lipid levels were found. Nineteen out of 40 (48%) of patients developed cardiovasculat complications during the trial; 11 had cerebrovascular attacks, 5 coronary occlusion and 3 thromboembolism in the leg. There was a significant increase in serum triglyceride levels in all patients who developed vascular disorders, whereas the changes in serum cholesterol and total lipids were not significant. The results suggest a possible association between the increase of serum triglycerides and the development of thromboembolic complications.Keywords
This publication has 11 references indexed in Scilit:
- Body Fluid and Electrolyte Balance During Estrogen Therapy of Prostatic CancerJournal of Urology, 1974
- Effect of Estrogen on the Serum Cholesterol and Triglyceride Levels of Prostatic Cancer PatientsJournal of Urology, 1971
- Thromboembolism During Estrogen Therapy of Prostatic Cancer: Report on Two CasesScandinavian Journal of Urology and Nephrology, 1971
- Estrogen treatment for cancer of the prostate.Early results with 3 doses of diethylstilbestrol and placeboCancer, 1970
- Relationship of Estrogen Therapy for Carcinoma of the Prostate to Atherosclerotic Cardiovascular Disease: A Clinicopathologic StudyJournal of Urology, 1970
- THROMBOEMBOLISM AND ŒSTROGEN THERAPYThe Lancet, 1967
- Risk Factors in Coronary Heart Disease: An Evaluation of Several Serum Lipids as Predictors of Coronary Heart Disease: The Framingham StudyAnnals of Internal Medicine, 1964
- INFLUENCE OF REDUCTION OF SERUM LIPIDS ON PROGNOSIS OF CORONARY HEART-DISEASE A Five-year Study Using $OElig;strogenThe Lancet, 1961
- Serum Lipids in Men with Myocardial InfarctionActa Medica Scandinavica, 1960
- Influence of gonadal hormones on protein-lipid relationships in human plasmaAmerican Journal Of Medicine, 1955